XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,037,063 | -9.7% | 59,633 | +1.8% | 0.00% | 0.0% |
| Q2 2023 | $2,255,831 | +1497.3% | 58,593 | +1384.9% | 0.00% | – |
| Q1 2023 | $141,227 | +218.9% | 3,946 | +251.4% | 0.00% | – |
| Q4 2022 | $44,280 | +146.0% | 1,123 | +124.6% | 0.00% | – |
| Q3 2022 | $18,000 | +350.0% | 500 | +66.7% | 0.00% | – |
| Q4 2019 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | 0.0% | 300 | -33.3% | 0.00% | – |
| Q2 2018 | $4,000 | +100.0% | 450 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -71.4% | 450 | -81.7% | 0.00% | – |
| Q4 2017 | $7,000 | 0.0% | 2,464 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | -12.5% | 2,464 | 0.0% | 0.00% | – |
| Q2 2017 | $8,000 | -20.0% | 2,464 | 0.0% | 0.00% | – |
| Q1 2017 | $10,000 | -47.4% | 2,464 | -2.0% | 0.00% | – |
| Q4 2016 | $19,000 | -5.0% | 2,514 | +2.0% | 0.00% | – |
| Q3 2016 | $20,000 | +17.6% | 2,464 | -15.8% | 0.00% | – |
| Q2 2016 | $17,000 | -50.0% | 2,925 | -40.6% | 0.00% | – |
| Q1 2016 | $34,000 | -8.1% | 4,925 | +7.9% | 0.00% | – |
| Q4 2015 | $37,000 | +94.7% | 4,564 | +101.6% | 0.00% | – |
| Q3 2015 | $19,000 | -36.7% | 2,264 | -13.4% | 0.00% | – |
| Q2 2015 | $30,000 | -64.3% | 2,614 | -47.0% | 0.00% | – |
| Q1 2015 | $84,000 | -38.2% | 4,928 | -28.2% | 0.00% | – |
| Q4 2014 | $136,000 | – | 6,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |